Legend Biotech to be involved in the Annual J.P. Morgan Healthcare that is 39th Conference
Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a worldwide clinical-stage biopharmaceutical business involved in the development and development of novel mobile treatments for oncology and other indications, will take part practically within the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021. Ying Huang, PhD, ceo and Chief Financial Officer of Legend Biotech, will show business updates on January 13, 2021 at 4:30 pm ET wednesday.
Ares Commercial Property Corporation Declares Fourth Quarter 2020 Dividend
Ares Commercial real-estate Corporation (“ACRE”) (NYSE:ACRE) announced today it declared a 4th quarter 2020 cash dividend of $0.33 per typical share. The dividend is payable on January 15, 2021 to stockholders of record at the time of the close of company on December 30, 2020.
NuLegacy Completes First Four Holes In Brand Brand New Rift Anticline Target
Confirms gold-bearing that is large hydrothermal systemRENO, Nev., Dec. 15, 2020 (GLOBE NEWSWIRE) NuLegacy Gold Corporation is very happy to report regarding the very very very first four holes of this initial 16-hole reconnaissance drilling system prepared for the formerly untested Rift Anticline research target. Overview: the very first four holes have provided additional evidence that is strong the Rift Anticline possibly hosts a high-grade Goldrush design silver deposit: * with extremely thick perspectives (up to 175+/- metres) of favourable Wenban product 5 (W5) stratigraphy, * that have encountered intense structural deformation and alteration and search to host two, possibly three, parallel anticlinal features along almost all of its 6 km strike.Holes RA2020-01 and -02 were drilled to a level of 585 and 630 metres and also have been logged, split, and assayed for gold (trace element analyses nevertheless in progress).